Literature DB >> 28446394

[Expressions of OCT4, Notch1 and DLL4 and their clinical implications in epithelial ovarian cancer].

Lan Yu1, Yun-Jie Jiao, Lei Zhou, Wen-Qing Song, Shi-Wu Wu, Dan-Na Wang.   

Abstract

OBJECTIVE: To investigate the correlations among OCT4, Notch1 and DLL4 and their association with the clinicopathological features of patients with epithelial ovarian cancer (EOC).
METHODS: A total of 207 specimens of EOC and 65 specimens of benign ovarian epithelial tumor tissues were examined for expressions of OCT4, Notch1 and DLL4 proteins using immunohistochemistry.
RESULTS: The positivity rates of OCT4, Notch1 and DLL4 in EOC tissues were 60.0%, 61.8% and 60.9%, respectively, significantly higher than the rates in benign epithelial tumor tissues (9.2%, 6.2%, and 0, respectively; P<0.05). The expressions of OCT4, Notch1 and DLL4 in EOC were significantly correlated with tumor differentiation, FIGO stage, and lymph node metastasis (P<0.05). DLL4 was positively correlated with OCT4 and Notch1 expressions (r=0.758 and 0.704, respectively, P<0.001), and the latter two were also positively correlated (r=0.645, P<0.001). Overexpressions of OCT4, Notch1 and DLL4 were associated with a poor prognosis, and the survival rate was significantly lower in patients positive for OCT4, Notch1, and DLL4 than in the negative patients (P<0.05). FIGO stage and expressions of OCT4 and DLL4 were independent prognostic factors of EOC (P<0.05).
CONCLUSION: The expressions of OCT4, Notch1 and DLL4 are correlated with the differentiation, lymph node metastasis, clinical stage and prognosis of EOC. Combined detection of the 3 proteins has an important value in predicting the progression and prognosis of EOC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28446394      PMCID: PMC6744103     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  24 in total

Review 1.  Cancer stem cells: a new framework for the design of tumor therapies.

Authors:  Boyan K Garvalov; Till Acker
Journal:  J Mol Med (Berl)       Date:  2010-10-02       Impact factor: 4.599

2.  Expression of octamer-4 in serous and mucinous ovarian carcinoma.

Authors:  Jing Zhang; Yan-Li Li; Cai-Yun Zhou; Yu-Ting Hu; Huai-Zeng Chen
Journal:  J Clin Pathol       Date:  2010-10       Impact factor: 3.411

3.  The relationship between vascular oxygen distribution and tissue oxygenation.

Authors:  Alexandru Daşu; Iuliana Toma-Daşu
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 4.  The role of epigenetic mechanisms in Notch signaling during development.

Authors:  Ralf Schwanbeck
Journal:  J Cell Physiol       Date:  2015-05       Impact factor: 6.384

Review 5.  Passing the baton: the HIF switch.

Authors:  Mei Yee Koh; Garth Powis
Journal:  Trends Biochem Sci       Date:  2012-07-18       Impact factor: 13.807

Review 6.  Protective or pathogenic effects of vascular endothelial growth factor (VEGF) as potential biomarker in cerebral malaria.

Authors:  Miriam Canavese; Roberta Spaccapelo
Journal:  Pathog Glob Health       Date:  2014-03-07       Impact factor: 2.894

Review 7.  Notch signaling and breast cancer.

Authors:  Michael Reedijk
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

8.  Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.

Authors:  Irene Noguera-Troise; Christopher Daly; Nicholas J Papadopoulos; Sandra Coetzee; Pat Boland; Nicholas W Gale; Hsin Chieh Lin; George D Yancopoulos; Gavin Thurston
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

9.  Coexpression of stemness factors Oct4 and Nanog predict liver resection.

Authors:  Xin Yin; Yi-Wei Li; Bo-Heng Zhang; Zheng-Gang Ren; Shuang-Jian Qiu; Yong Yi; Jia Fan
Journal:  Ann Surg Oncol       Date:  2012-03-30       Impact factor: 5.344

Review 10.  Stem cells, stress, metabolism and cancer: a drama in two Octs.

Authors:  Jinsuk Kang; Arvind Shakya; Dean Tantin
Journal:  Trends Biochem Sci       Date:  2009-09-04       Impact factor: 13.807

View more
  2 in total

Review 1.  The Role of DLLs in Cancer: A Novel Therapeutic Target.

Authors:  Meng-Xi Xiu; Yuan-Meng Liu; Bo-Hai Kuang
Journal:  Onco Targets Ther       Date:  2020-05-07       Impact factor: 4.147

2.  MicroRNA-744 Inhibits Cellular Proliferation and Invasion of Colorectal Cancer by Directly Targeting Oncogene Notch1.

Authors:  Jian Shen; Minzhe Li
Journal:  Oncol Res       Date:  2018-02-22       Impact factor: 5.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.